Atlas Trials

An Open-randomized, Balanced, Crossover Bioequivalence Study to Compare One MR Tablet of 60 mg Gliclazide and Two MR Tablets of 30 mg Gliclazide in Healthy Subjects

Clinical trial NCT01195532 · UNKNOWN

Trial details

NCT number
NCT01195532
Sponsor
Taipei Medical University WanFang Hospital
Status
UNKNOWN
Study type
OBSERVATIONAL
HyperglycemiaDiabetes
Start date
2010-01-01
Primary completion
2011-01-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.